Skip to content
Home/Companies/Biotech/Ganymed Pharmaceuticals
GP

Ganymed Pharmaceuticals

Biotech·Germany·Exited 2016·Held 9yr

Ganymed Pharmaceuticals is a biotech company, headquartered in Germany.

Entry
2007
Hold
9yr
Exit
2016
Est. EV
–

Who owns Ganymed Pharmaceuticals?

Ganymed Pharmaceuticals was owned by MIG Capital through MIG Fonds 5 (2007 vintage) from 2007 to 2016, exited via Trade Sale. Across its history, Ganymed Pharmaceuticals has been through 2 private equity ownership periods, detailed in the timeline below.

Buyer identity available on Pro.

Hand-verified · updated 2026-07-03

MIG Capital
Most recent investor
MIG Capital
MIG Fonds 5 · 2007 · Evergreen
2 ownership periods · full history below

Key facts

HQGermany
SectorBiotech
StatusAcquired
Key takeaways
  • ·Fully exited in 2016.
  • ·Average hold across 2 realized cycles: 12 years.

Ownership history

2 ownership periods · co-invest detected

Exited
Last exited in 2016 to .
Co-invest · 2 holders · 2001 · 2016
Athos
AthosExited 2016
2001 · 2016 · Athos Evergreen Life Sciences · 2001 · Evergreen
Trade Sale · to
MOIC
–
MIG Capital
MIG CapitalExited 2016
2007 · 2016 · MIG Fonds 5 · 2007 · Evergreen
Trade Sale · to
MOIC
–

More from MIG Fonds 5

Other portfolio companies in the same fund.

advanceCOR
Active
BiotechGermany· 2012
Immatics
Active
BiotechGermany· 2010
AmSilk
Active
BiotechGermany· 2008
instrAction
Active
Deep TechGermany· 2008
OD-OS
Active
MedTechGermany· 2008
SuppreMol
Exited 2015
BiotechGermany· 2007
to

More PE-backed in Biotech

Comparable biotech deals from other GPs.

GenSight Biologics
Active
Sofinnova PartnersFrance
InBrain Pharma
Active
Finovam GestionFrance
Isavy Biotech
Active
Ring CapitalFrance
NeoVacs
Active
Odyssée VentureFrance
ReNeuron Group
Exited 2024
Obotritia CapitalUnited Kingdom
Univercells
Exited 2023
AdBio PartnersBelgium
to
Data refreshed weekly · Sourced from public filings